Leukemic

Evidence links anemia drugs with leukemic transformation in patients with primary myelofibrosis

ATLANTA -- Mayo Clinic researchers today reported the discovery of a link between erythropoiesis-stimulating agents (ESAs) and leukemic transformation (conversion to leukemia) of the blood disorder myelofibrosis. The results of the retrospective study, which sought to quantify the risk factors for...

Blood camp held in Alaska to save leukemic patients

Susan Butcher the famous iditarod champion was detected with leukemia. She was looking forward to participate in the 300-mile sled dog race conducted in this winter // . She is the four times winner of the 1100-mile Iditarod Trail Sled Dog Race. She said that she will win this race of survival ...

Leukemia cells evade immune system by mimicking normal cells, Stanford studies show

...y that leukemia cells in mice also expressed CD47 led us to propose that this signal might be appropriated by the leukemia stem cells as part of their leukemic progression," said Weissman. Jaiswal and his colleagues went on to show that although rapidly proliferating myeloid leukemia cells in human patient...

Latest Berry Health Benefits Revealed

...d Black Raspberries" Gary Stoner, Ph.D., Ohio State University "Cyanidin-3-Rutinoside, a Natural Polyphenol Antioxidant, Selectively Kills leukemic Cells by Induction of Oxidative Stress" Xiao-Ming Yin, Ph.D., University of Pittsburgh School of Medicine Complete studies will be publis...

Taking Aim at Relapse of Leukemia in Kids

...agues found that a protein receptor (CCR7) embedded on the outer surface of leukemic cells enables the cancer cells to infiltrate the brain and spinal cord. "What we have found is that leukemic cells over-express this receptor," Aifantis said. "If you knock out this re...

Mapping gene expression with Gene Expression Atlas

...genes are expressed in a particular condition? For example, what genes are specifically active in kidney cells, or how does the expression of genes in leukemic blood differ compared to normal blood? Both questions can also be combined to focus on particular genes and their role in a specific disease, such...

Donor Stem-Cell Transplant Best For Acute Myeloid Leukemia

... Medical Center, described the study as a very thoughtful analysis of a complex problem. "It does reinforce that the cytogenetic abnormality in the leukemic cells of a patient are a singularly important factor, but not the only factor, in determining the therapeutic approach," Lichtman said. "As the aut...

Ludwig Institute of Cancer Research Ltd., Brussels Branch, Issues Statement Concerning Prospect Therapeutics Inc's. GCS-100 Molecule

...e of human cancers. Prospect reported that GCS-100 could induce apoptosis of cancer cells and that clinical trial results indicated that reduction in leukemic cell number could be obtained without severe side effects. "In addition to its direct effect on tumor cells, GCS-100 could have an important role...

ChemGenex's omacetaxine may provide first viable treatment option for highly resistant form of CML

...m of action, specifically binding to the ribosomal A-site cleft and inhibiting protein translation of short-lived oncoproteins that are upregulated in leukemic cells (particularly Cyclin-D1, Mcl-1 and c-Myc). As omacetaxine acts independently of tyrosine kinase inhibitors, it may have a therapeutic advantage ...

Celator(R) Pharmaceuticals Presents New Data on CPX-351 And CPX-1 at the American Association for Cancer Research

...er." In the first presentation, researchers reported that CPX-351 was superior to standard cytarabine:daunorubicin free-drug cocktail in ablating leukemic bone marrow cells in the CCRF-CEM human leukemia xenograft model. Additional data showed median survival was improved by consolidation treatment with...

Leukemic in Medical Technology

Cephalon Provides Clinical Update on Lestaurtinib in Relapsed Acute Myelogenous Leukemia

...." Developed by Cephalon scientists, lestaurtinib is a potent inhibitor of several tyrosine kinases including FLT3 and a Janus kinase (JAK2). In leukemic cells, lestaurtinib inhibits FLT3 activity and induces cell death (apoptosis). In myeloproliferative disorders, mutations in JAK2 may play a role in a...

Bayer Announces Leukine(R) Data Presentations at 45th American Society of Clinical Oncology (ASCO) Annual Meeting

...lowing induction chemotherapy in older adults with AML. Important Safety Considerations Leukine is contraindicated in patients with excessive leukemic blasts in bone marrow or peripheral blood (10 percent), in patients with known hypersensitivity to GM-CSF, yeast derived products or any component of ...

Mutant Genes in High-Risk Childhood Leukemias Identified

... the researchers' previous genetic analysis of the leukemic cells from pediatric ALL patients. "The findi...hinery of white blood cells. The team analyzed the leukemic cells from 187 patients with high-risk ALL. That a...ch JAK mutations have been identified within their leukemic cells." Such studies would be coordinated by...

Foundation Venture Capital Group Invests in UMDNJ Company Working to Improve Leukemia Treatments

...s proud to announce that the company has made a $500,000 commitment to Actinobac Biomed Inc., a company developing a therapeutic agent targeting white leukemic blood cells for the treatment of hematological malignancies, including leukemia, myeloma and lymphoma. "Based on current statistics, one can see ...

St. Jude Finds More Than 100 Gene Variations Linked With Response to Leukemia Treatment

...use those studies focused only on the genes of the leukemic cells themselves," said Mary Relling, Pharm.D., St...ed and affects all cells in the body, not just the leukemic cells." Relling is the senior author of a report o...residual disease (MRD). MRD is the small number of leukemic cells that survive after remission induction thera...

Gene Abnormality Found to Predict Childhood Leukemia Relapse

...ng that the cells are less mature and possibly more resistant to the effects of drugs used to treat ALL. "These findings show how detailed analysis of leukemic cells using complementary techniques can enhance our understanding of the genetic basis of leukemia," said co-author Cheryl Willman, M.D., director an...

Journal of Clinical Oncology Publishes Leukine(R) Study Demonstrating Positive Survival Outcomes in Patients with High-Risk Melanoma

...h following induction chemotherapy in older adults with AML. Important Safety Considerations Leukine is contraindicated in patients with excessive leukemic blasts in bone marrow or peripheral blood (10 percent), in patients with known hypersensitivity to GM-CSF, yeast derived products or any component of ...

The Leukemia & Lymphoma Society and Memgen Collaborate on CLL Clinical Trial

... of ISF35 resulted in the rapid decline in circulating and lymph node bound leukemic cells, induced long-term immune based responses against these cells and sen...35's results are achieved through its ability to bind to a protein found on leukemic B lymphocytes. This activates a natural immune process that causes malignan...

Study Supports Possible Use of Leukine(R) as a Potential Adjuvant Therapy for High-Risk Melanoma Patients

... mcg in single-use vial ready for sterile reconstitution Important Safety Considerations Leukine is contraindicated in patients with excessive leukemic blasts in bone marrow or peripheral blood (10%), in patients with known hypersensitivity to GM-CSF, yeast derived products or any component of Leukine...

Molecular Science Could Further Improve Leukemia Survival, Say St. Jude Researchers

...ses to drugs. Some ALL specialists envision a time when oncologists use leukemic cell genetics and host pharmacogenetics to match specific treatments to individual patients. "We need to know the leukemic cell genetics that affect drug sensitivity or resistance and what role phar...

Leukemic in Medical Products

Chromosome Analysis, Leukemic Blood

Description: ARUP Laboratories is a national reference laboratory and a worldwide leader in innovative laboratory research and development. ARUP offers an extensive test menu of highly complex and unique medical tests in clinical and anatomic pathology. Owned by the University of Utah, ARUP Laboratories' client...
Company:ARUP Laboratories

Leukemic in Medical Dictionary

Hairy cell leukemia

...mia experience signs ... Fighting leukemia , lymphoma, Hodgkin's disease and myeloma. ... It is called " hairy cell leukemia " because the leukemic lymphocytes have short, ... Hairy Cell Leukemia . No. 16 in a series providing the latest ... The symptoms of hairy cell leukemia are n...

Granulocyte

... Original Article from The New England Journal of Medicine -- Granulocyte -Macrophage Progenitors as Candidate leukemic Stem Cells in Blast-Crisis CML Original Article from The New England Journal of Medicine -- Mutations in the Gene for the Granulocyte Colony-Sti...

Leukemic in Biological News

The very unexpected life and death of a leukemic cell

B cell chronic lymphocytic leukemia (CLL) is an incurable disease in which cells in the bone marrow grow and survive to the point where they become abnormal and malignant (leukemic). The progression of the disease is slow and there has been a lack of information regarding the rate of production of ...

Scientists identify key gene that protects against leukemia

...ritical roles in determining cell fate. "By uncovering this mechanism, we might one day be able to determine the difference between normal HSCs and leukemic stem cells in gene regulatory networks. This could allow us to develop more targeted therapies. These kinds of therapeutic applications are still down...

A miR boost enables acute leukemia cells to mature

... study discovered how the miR reactivates silenced genes, which enables the leukemic cells to differentiate and mature, important steps that precede their death...l groups) to genes. When the researchers raised the level of miR-29b in leukemic cells, the amount of a third enzyme, called DNMT1, fell. "We discovered...

Innovations in Pediatric Medicine CME conference brings together national pediatrics experts

... Stem Cell Therapy in Children Dr. Ruth L. Fischbach, Columbia University Medical Center 3:00 3:30 p.m. Molecular Characterization of Normal and leukemic Stem Cells Dr. David A. Williams, Children's Hospital of Boston and Harvard Medical School 3:30 4:00 p.m. Panel Discussion with Q&A Sunday...

Two suppressor molecules affect 70 genes in leukemia

...elf-destruction. In CLL, however, the gene behaves abnormally and helps the leukemic cells survive long after they should have died. Croce and his colleagues...letely suppressed tumor growth in three of five animals. Mice injected with leukemic cells that lacked the two molecules, on the other hand, developed significa...

St. Jude identifies the specific cell that causes eye cancer, disproving long-held theory

...ma also challenges the established scientific belief that cancer cells are most aggressive when they are undifferentiated, Dyer said. For example, the leukemic cells of chronic myelogeneous leukemia (CML) are much less aggressive when they are differentiated; and it is generally not aggressive until the tumor...

St. Jude finds factors that accelerate resistance to targeted therapy in lymphoblastic leukemia

...atients at high risk of failing this treatment by determining whether their leukemic cells lack the Arf gene, said Richard T. Williams, M.D., Ph.D., an assistan...t also block the ability of other factors in the bone marrow to sustain the leukemic cells should render them more susceptible to imatinib and improve the outco...

Leukemia drug turns mini-molecules up, cancer genes down

...a form of vitamin A used to treat acute promyelocytic leukemia induces changes in an unusual class of small molecules called microRNAs (miRNAs) in the leukemic cells. The study also shows that three of these miRNAs inhibit the action of two genes important for cancer development, helping to explain how the ...

Major gene study uncovers secrets of leukemia

...ese mutations reduced the level of PAX5 protein in leukemic cells or resulted in the formation of PAX5 protein...s to differentiate into B lymphocytes. In ALL, the leukemic cells fail to differentiate normally and instead r...re stage of development. Locked in this state, the leukemic cells continue to proliferate, and this continual ...

Leukemic cells find safe haven in bone marrow

...s in the bone marrow create a protective niche for leukemic cells by releasing large amounts of asparagine, an amino acid that nearby leukemic cells must have to survive but do not make efficiently. This extra supply of asparagine helps leukemic cells survive treatment with asparaginase, a drug ...

Leukemic in Biological Technology

ARIUS presents new findings showing therapeutic antibody inhibits human leukemic cancer stem cells

- Data on ARIUS' novel CD9 therapeutic antibody to be presented at AACR Special Conference on Cancer Stem Cells - TORONTO, Feb. 13 /PRNewswire-FirstCall/ - ARIUS Research Inc., (TSX: ARI), a biotechnology company discovering and developing the next wave of antibody therapeutics, ...

Celator(R) Pharmaceuticals Presents Data on the Activity of CPX-351 Against Leukemia at the European Hematology Association Congress

...d in vivo (mouse xenograft models).(2) They reported that CPX-351 ablated leukemic cells but permitted the regrowth of normal bone marrow cells within 42 days...racellularly, and demonstrated that CPX-351 is taken up in higher levels by leukemic cells in the bone marrow than by normal bone marrow cells. They concluded ...

Alfacell's ONCONASE(R) and R-Amphinase Show Anti-Tumor Activity in Chronic Lymphocytic Leukemia and Acute Myeloblastic Leukemia Cells

...nclude a related endoribonuclease, R-Amph. For the study in CLL, leukemic cells were isolated from 36 untreated patients with CLL and were cultured f...ism with the most widely used CLL therapies. For the study in AML, leukemic cells isolated from 22 patients with newly diagnosed AML were cultured for ...

Lorus Therapeutics Reports Fourth Quarter Results for Fiscal Year 2008

... responses in 35% of the 23 patients and significant cytoreduction of leukemic blasts in two others. Moreover, the clinical responses correlated with...demonstration of intracellular LOR-2040 in circulating and bone marrow leukemic cells. - Signed an exclusive multinational license agreement with Zor ...

Lorus Therapeutics Announces Publication of a Clinical Study Demonstrating Encouraging Results with LOR-2040 in Combination with Cytarabine in Patients with Acute Myeloid Leukemia (AML)

...mplete responses in 35% of the 23 patients and significant cytoreduction of leukemic blasts in two others. As a further favourable outcome, these two patients a...cal study also measured intracellular uptake of LOR-2040 in the bone marrow leukemic cells, and identified significant accumulation of the drug in the bone marr...

ARIUS presents new findings for anti-cancer antibody programs at AACR

...cer Stem Cell Program Anti-CD9 antibody, AR40A746.2.3, inhibits tumor growth in pancreatic and breast cancer models and recognizes CD9 on CD34+CD38- leukemic cancer stem cells. Abstract Number 3993. Experimental and Molecular Therapeutics 32, Tuesday, April 15, 2008, 8:00 AM ARIUS has demonstrated that tr...

ARIUS announces five abstracts selected for presentation at 2008 AACR Annual Meeting

...bstract Number 3993: "Anti-CD9 antibody, AR40A746.2.3, inhibits tumor growth in pancreatic and breast cancer models and recognizes CD9 on CD34+CD38- leukemic cancer stem cells." Experimental and Molecular Therapeutics 32, Tuesday, April 15, 2008, 8:00 AM Abstract Number 3995: "A monoclonal antibody targ...

Center for Molecular Medicine Selected to Provide DNA Analysis for Children's Oncology Group Leukemia Study

...s of DNA from pediatric leukemia patients' germline blood samples and their leukemic blasts. The CMM will identify and catalog potentially critical differences ...n tiny variations found within human genomes, including naturally, DNA from leukemic specimens. A genome is the complete DNA sequence present in every cell of a...

AEterna Zentaris to Further Develop Three Follow-up Multi-targeted Cytotoxic Candidates to AEZS-112 as Potential Novel Cancer Treatment

... or twice weekly, AEZS-112 proved to be a potent inhibitor of in vivo tumor growth in different models including mammary, colon, skin, lung, renal and leukemic cancers. About AEterna Zentaris Inc. AEterna Zentaris Inc. is a global biopharmaceutical company focused on endocrine therapy and oncology with prov...

Lorus Advances Clinical Development of GTI-2040 Combined with Ara-C in Acute Myeloid Leukemia

...egulation of R2, the cellular target of GTI-2040, and were further supported by demonstration of intracellular GTI-2040 in circulating and bone marrow leukemic cells. Complete results from the clinical trial are expected to be presented by the investigators in a scientific publication. "The initiation of an ...

Leukemic in Biological Dictionary

Transformed phenotype

...on-induced cells did not show the transformed phenotype . ... ... parva induces a transformed phenotype with characteristics comparable to leukemic cells. The transformed phenotype reverts on drug-induced parasite death, and ... ...

G1 phase

...ped growth and were arrested with a G1 phase amount of DNA. ... (10 , 11) also showed that cyclin B1 accumulated at the G1 phase in human leukemic cell lines. ... sort subgroups in the G1 phase , the cells were first labeled ... G1 phase is the first gap (G) between the activity of ...